Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1215604.RAFBioRgN7Es2e-nZGdM-Ob-Vo5Or9PgDm1iJrKQJsfcI130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1215604.RAFBioRgN7Es2e-nZGdM-Ob-Vo5Or9PgDm1iJrKQJsfcI130_assertion type Assertion NP1215604.RAFBioRgN7Es2e-nZGdM-Ob-Vo5Or9PgDm1iJrKQJsfcI130_head.
- NP1215604.RAFBioRgN7Es2e-nZGdM-Ob-Vo5Or9PgDm1iJrKQJsfcI130_assertion description "[Sorafenib and nilotinib resensitize tamoxifen resistant breast cancer cells to tamoxifen treatment via estrogen receptor ?.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1215604.RAFBioRgN7Es2e-nZGdM-Ob-Vo5Or9PgDm1iJrKQJsfcI130_provenance.
- NP1215604.RAFBioRgN7Es2e-nZGdM-Ob-Vo5Or9PgDm1iJrKQJsfcI130_assertion evidence source_evidence_literature NP1215604.RAFBioRgN7Es2e-nZGdM-Ob-Vo5Or9PgDm1iJrKQJsfcI130_provenance.
- NP1215604.RAFBioRgN7Es2e-nZGdM-Ob-Vo5Or9PgDm1iJrKQJsfcI130_assertion SIO_000772 25175082 NP1215604.RAFBioRgN7Es2e-nZGdM-Ob-Vo5Or9PgDm1iJrKQJsfcI130_provenance.
- NP1215604.RAFBioRgN7Es2e-nZGdM-Ob-Vo5Or9PgDm1iJrKQJsfcI130_assertion wasDerivedFrom befree-2016 NP1215604.RAFBioRgN7Es2e-nZGdM-Ob-Vo5Or9PgDm1iJrKQJsfcI130_provenance.
- NP1215604.RAFBioRgN7Es2e-nZGdM-Ob-Vo5Or9PgDm1iJrKQJsfcI130_assertion wasGeneratedBy ECO_0000203 NP1215604.RAFBioRgN7Es2e-nZGdM-Ob-Vo5Or9PgDm1iJrKQJsfcI130_provenance.